German Christopher Paul bought RYTM
March 1, 2026 · Form 4 insider transaction
German Christopher Paul bought 1,162 shares of Rhythm Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,162
Price
N/A
Total value
N/A
InsiderGerman Christopher Paul
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after4,595
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.